141 related articles for article (PubMed ID: 1495742)
1. Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
Misawa T; Kikkawa F; Oguchi H; Morikawa Y; Kawai M; Maeda O; Iwata M; Kano T; Furuhashi Y; Tomada Y
Oncology; 1992; 49(3):173-9. PubMed ID: 1495742
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells.
Misawa T; Kikkawa F; Maeda O; Obata NH; Higashide K; Suganuma N; Tomoda Y
Jpn J Cancer Res; 1995 Jan; 86(1):88-94. PubMed ID: 7737915
[TBL] [Abstract][Full Text] [Related]
3. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
[TBL] [Abstract][Full Text] [Related]
4. Potentiating effect of amphotericin B on five platinum anticancer drugs in human cis-diamminedichloroplatinum (II) sensitive and resistant ovarian carcinoma cells.
Kikkawa F; Kojima M; Oguchi H; Maeda O; Ishikawa H; Tamakoshi K; Mizuno K; Kawai M; Suganuma N; Tomoda Y
Anticancer Res; 1993; 13(4):891-6. PubMed ID: 8352556
[TBL] [Abstract][Full Text] [Related]
5. Glutathione related enzymes in cis-diamminedichloroplatinum (II)-sensitive and-resistant human ovarian carcinoma cells.
Oguchi H; Kikkawa F; Kojima M; Maeda O; Mizuno K; Suganuma N; Kawai M; Tomoda Y
Anticancer Res; 1994; 14(1A):193-200. PubMed ID: 7909418
[TBL] [Abstract][Full Text] [Related]
6. In vitro antitumor activity of a new platinum complex, DWA2114R against human tumor cell lines.
Akamatsu K; Saito H; Tsunenari T; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Anticancer Res; 1993; 13(6A):2261-5. PubMed ID: 8297143
[TBL] [Abstract][Full Text] [Related]
7. Antitumor activity and cellular accumulation of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) monohydrate, in cisplatin-sensitive and -resistant murine P388 leukemia cells.
Kamisango K; Matsumoto T; Akamatsu K; Morikawa K; Tashiro T; Koizumi K
Jpn J Cancer Res; 1992 Mar; 83(3):304-11. PubMed ID: 1582895
[TBL] [Abstract][Full Text] [Related]
8. Heat enhances the cytotoxicity of cis-diamminedichloroplatinum(II) and its analogues cis-1,1-cyclobutane-dicarboxylato(2R)-2-methyl-1,4- butanediammineplatinum(II) and cis-diammine(glycolato)platinum in vitro.
Takahashi I; Maehara Y; Kusumoto H; Kohnoe S; Sugimachi K
Cancer Chemother Pharmacol; 1993; 33(1):31-5. PubMed ID: 8269586
[TBL] [Abstract][Full Text] [Related]
9. In vitro and in vivo antineoplastic activity of a new platinum antineoplastic agent, (R)-(-)-1,1-cyclobutanedicarboxylate (2-aminomethylpyrrolidine)-platinum (II) (DWA2114R) on freshly separated human tumor cells and human tumor xenografts transplanted in nude mice--a comparison with cis-diammine-dichloroplatinum (CDDP).
Nio Y; Imai S; Shiraishi T; Tsubono M; Morimoto H; Tseng CC; Tobe T
Anticancer Res; 1991; 11(2):761-7. PubMed ID: 2064331
[TBL] [Abstract][Full Text] [Related]
10. Toxicological and tumoricidal evaluations of a new platinum complex, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato+ ++)platinum( II) monohydrate, in rats.
Akamatsu K; Endo K; Matsumoto T; Morikawa K; Koizumi M; Koizumi K; Mitsui H
Jpn J Cancer Res; 1991 Jun; 82(6):724-31. PubMed ID: 1906857
[TBL] [Abstract][Full Text] [Related]
11. The interactions of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) and related compounds with deoxyribonucleic acid.
Morikawa K; Matsumoto T; Matsuoka Y; Koizumi K
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):212-9. PubMed ID: 1576676
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14/CDDP).
Ohmori T; Morikage T; Sugimoto Y; Fujiwara Y; Kasahara K; Nishio K; Ohta S; Sasaki Y; Takahashi T; Saijo N
Jpn J Cancer Res; 1993 Jan; 84(1):83-92. PubMed ID: 8383649
[TBL] [Abstract][Full Text] [Related]
13. A new anticancer platinum compound, (-)-(R)-2-aminomethyl-pyrrolidine(1,1-cyclobutanedicarboxylato) platinum(II): DNA interstrand crosslinking, repair and lethal effects in normal human, Fanconi's anaemia and xeroderma pigmentosum cells.
Fujiwara Y; Nakamura M; Yokoo S
Br J Cancer; 1993 Jun; 67(6):1285-92. PubMed ID: 8512813
[TBL] [Abstract][Full Text] [Related]
14. cis-diamminedichloroplatinum(II)-resistant sublines derived from two human ovarian tumor cell lines.
Kuppen PJ; Schuitemaker H; van 't Veer LJ; de Bruijn EA; van Oosterom AT; Schrier PI
Cancer Res; 1988 Jun; 48(12):3355-9. PubMed ID: 2897238
[TBL] [Abstract][Full Text] [Related]
15. Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant HeLa cells.
Minagawa Y; Kigawa J; Ishihara H; Itamochi H; Terakawa N
Jpn J Cancer Res; 1994 Sep; 85(9):966-71. PubMed ID: 7961127
[TBL] [Abstract][Full Text] [Related]
16. Abrogated energy-dependent uptake of cisplatin in a cisplatin-resistant subline of the human ovarian cancer cell line IGROV-1.
Ma J; Maliepaard M; Kolker HJ; Verweij J; Schellens JH
Cancer Chemother Pharmacol; 1998; 41(3):186-92. PubMed ID: 9443634
[TBL] [Abstract][Full Text] [Related]
17. Potent antitumour activity of (-)-(R)-2-aminomethylpyrrolidine (1,1-cyclobutanedicarboxylato)platinum(II) monohydrate (DWA2114R) against advanced L1210 leukaemia in mice.
Akamatsu K; Endo K; Matsumoto T; Kamisango K; Morikawa K; Koizumi M; Koizumi K
Br J Cancer; 1992 Nov; 66(5):827-32. PubMed ID: 1419625
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
[TBL] [Abstract][Full Text] [Related]
19. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
20. Possible mechanisms of resistance to cis-diamminedichloroplatinum (II) of human ovarian cancer cells.
Kikuchi Y; Iwano I; Miyauchi M; Kita T; Sugita M; Tenjin Y; Nagata I
Jpn J Cancer Res; 1990; 81(6-7):701-6. PubMed ID: 2119370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
